Sachith Gallolu

Sachith earned his Ph.D. in cancer biology from the University of Texas Southwestern Medical Center, where his research work involved understanding novel functions of the WNK signaling pathway. Following his Ph.D., Sachith worked as a Postdoctoral researcher at the University of Texas Southwestern Medical Center and City of Hope. In his academic research, he worked extensively on intracellular trafficking, protein kinases, and cellular signaling. Following his transition to the biotech industry, Sachith led and participated in multiple therapeutic antibody development projects that focused on multi-specific antibodies and antibody-drug conjugates.

As a Senior Scientist at Prellis, Sachith is part of developing the EXIS platform and leveraging its unique features to expand the current immunological capabilities and bring novel therapeutics to clinic to help patients in need. He likes to travel in his free time.